TX-GUIDEWIRE-SOFTWARE
13.6.2016 14:56:04 CEST | Business Wire | Press release
At the IASA conference, Guidewire Software, Inc. (NYSE: GWRE), a provider of software products to Property/Casualty (P/C) insurers, today announced the new release of the Guidewire Insurance Platform™ . The Guidewire Insurance Platform combines three elements — core operations, data and analytics, and digital engagement — that work together to enhance insurers’ ability to respond to industry changes and better engage and empower their customers, agents, and employees. Enhancements across the insurance platform reflect input from Guidewire’s 200+ customer community and enable insurers to improve agility and insight, optimize product offerings, streamline processes, and promote customer centricity.
“Property/Casualty insurers have faced more change in the last few years than in the previous few decades and the pace of change is set to accelerate,” said Scott Roza, chief business officer, Guidewire Software. “It’s incumbent upon the Guidewire team to keep evolving our products to ensure our customers can adapt and succeed in this dynamic environment. We’re very thankful for the insight and guidance that our engaged customer community has shared with us.”
“This release, an important milestone in our journey, features the simultaneous availability of new versions of our core, data, and digital products delivered as a unified whole,” said Ali Kheirolomoom, chief product officer, Guidewire Software. “And we’ve designed our platform to provide integrated experiences across the insurance lifecycle for specific user personas such as the underwriter, agent, claims adjuster, and IT professional. Additionally, InsuranceSuite 9 has been designed for public cloud deployment by our customers and partners.”
The latest release of the Guidewire Insurance Platform features new versions of InsuranceSuite, Digital Portals, DataHub, and InfoCenter. Key enhancements by product family include:
Core Operations:
Guidewire InsuranceSuite™ comprised of PolicyCenter, ClaimCenter, and BillingCenter supports insurers‘ core operations — underwriting, policy administration, billing, and claims management — across all lines of business. InsuranceSuite 9 enhancements include:
- Designed for cloud deployment, providing customers and Guidewire partners with flexible deployment options in private, public, or hybrid cloud environments.
- Visual configuration capabilities so that more system behavior, such as underwriting rules, can be made quickly and easily;
- Tailored user experience for the underwriter with integration across PolicyCenter and Spotlight - a Guidewire-hosted analytics application that enables more accurate and consistent property risk assessment;
- Claims straight-through invoice processing, so adjusters can manage by exception and claims vendors receive payments more quickly; and
- User-friendly Account and Policy Summary screens for fast, informed billing service to policyholders, and Equity Warnings to ensure sound business practices.
Data and Analytics:
Guidewire Data and Analytics, comprised of DataHub, InfoCenter, and Predictive Analytics, provides insurers with a Property/Casualty industry specific data store, business intelligence warehouse, and cloud predictive analytics products for claims and profitability. DataHub 9 and InfoCenter 9 enhancements include:
- Foundation tooling to automate and expedite delivery of data to DataHub - starting with BillingCenter - speeding business users’ time to analysis while lowering IT’s cost of development.
- Addition and consolidation of billing data and easy-to-use billing journals for accounts receivable, accounts payable, cash, and general billing transactions;
- Interactive data visualization to help agents understand new business growth requirements relative to customer churn, and embeddable and pre-integrated content with Guidewire Gateway Portal for Agents™; and
- New Loss Development App to support actuaries, claims managers, and regulatory reporting with easy data access and ability to pull pre-calculated loss development details for more complex analysis and flexible loss triangles.
Digital Engagement:
Guidewire Digital Portals™ provide support for omni-channel engagement across policy, billing, and claims to external stakeholders such as agents, policyholders, and vendors. Digital Portals 5 enhancements include:
- Mobile-first designed consumer quoting experience with very little data entry required;
- More self-serve capability for policyholders with a user experience that better meets the expectations set by other industries, e.g. retail;
- Configurable marketing sidebar in Gateway Portal for Agents allowing insurers to tailor marketing messages to agents – making them easy to find;
- Integration between Gateway Portal for Agents and InfoCenter enabling agents to see their performance analytics directly in the portal, empowering them to assess how they are growing and making money and where they should focus; and
- New wizard flow API in Digital Portals that simplifies the creation of unique user experiences.
The Guidewire Insurance Platform will be generally available (GA) worldwide* by June 30th. Guidewire ClaimCenter® 9, the company’s claims management product is available globally today.
About Guidewire Software
Guidewire delivers the software Property/Casualty insurers need to adapt and succeed in a time of rapid industry change. We combine three elements — core operations, data and analytics, and digital engagement — into an insurance platform that enhances insurers’ ability to engage and empower their customers and employees. More than 200 P/C insurers around the world have selected Guidewire. For more information, please visit www.guidewire.com . Follow us on twitter: @Guidewire_PandC .
* Guidewire Spotlight is only available in the United States and Canada (excluding Quebec).
NOTE: Guidewire, Guidewire Software, Guidewire ClaimCenter, Guidewire PolicyCenter, and Guidewire BillingCenter are registered trademarks of Guidewire Software, Inc. in the United States and/or other countries.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160613005329/en/
Contact:
Guidewire Software
Diana Stott, +1-650-356-4941
Director,
Communications
dstott@guidewire.com
or
onechocolate
Communications
Daniel Couzens/Susanna Woods, +44 (0)20 7437 0227
guidewire@onechocolatecomms.co.uk
or
Guidewire
Software (UK) Ltd
Louise Bradley, +44 (0)7474 837 860
lbradley@guidewire.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom